Anticardiolipin antibodies and acute myocardial infarction in non- systemic lupus erythmatosus patients: A controlled prospective study

American Journal of Medicine

Volumn 101, Issue 4, 1996, Pages 381-386

  Zuckerman, Eli ^a,b   Toubi, Elias ^a   Shiran, Avinoam ^a   Sabo, Edmund ^a   Shmuel, Zehava ^a   Golan, Theo Dov ^a   Abinader, Edward ^a   Yeshurun, Daniel ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ACUTE HEART INFARCTION; ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; HEART REINFARCTION; HUMAN; IMMUNOASSAY; ISCHEMIC HEART DISEASE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTRACRANIAL EMBOLISM AND THROMBOSIS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS;

EID: 0030272820     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00226-4     Document Type: Article

References (33)

1. 1. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ. 1983;287:1088-1089.
2. 2. Cervera R, Font J, Lopez-Soto A, et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis. 1990;49:109-113.
3. 3. Font J, Cervera R, Lopez-Soto A, et al. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations. Clin Rheumatol. 1989;8:475-483.
4. 4. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore). 1989;68:366-374.
5. 5. Font J, Lopez-Soto A, Cervera R, et al. The "primary" antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991;9:69-75.
6. 6. Levine SR, Welch KMA. The spectrum of neurologic disease. Association with antiphospholipid antibodies. Arch Neurol. 1987;44:876-883.
7. 7. Asherson RA, Khamashta MA, Gil A. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, "lupus like" disease and the "primary" antiphospholipid syndrome. Am J Ed. 1989;86:391-399.
8. 8. Harris EN, Gharavi AE, Asherson RA, et al. Cerebral infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Exp Rheumatol. 1984;2:47-51.
9. 9. Asherson RA, Khamashta MA, Baguley E, et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med. 1989;272:1103-1115.
10. 10. Rosner S, Ginzler EM, Diamond HS, et al. A multi-center study of outcome in systemic lupus erythematosus. Arthritis Rheum. 1982;25:612-617.
11. 11. Harvery AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus: a review of the literature and clinical analysis of 138 cases. Medicine (Baltimore). 1954;33:291-437.
12. 12. Bulkley SH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroids therapy. Am J Med. 1978; 58:243-264.
13. 13. Hamsten A, Norberg R, Bjorkholm M, et al. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986;i:113-116.
14. 14. Sletnes KE, Smith P, Abdelnoor N, et al. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-hemorrhagic stroke. Lancet. 1992;339:451-453.
15. 15. Sletnes KE, Larsen EW, Stokland O, Wisloff F. Antiphospholipid antibodies detected as anticephalin and anticardiolipin antibodies in patients with acute myocardial infarction: immunological response to myocardial necrosis? Thromb Res. 1990;59:675-680.
16. 16. Mattila A, Vaarala O, Palosuo T, et al. Serologie response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clin Immunol Immunopathol. 1989;51:414-418.
17. 17. Eber B, Kronberger-Schaffer E, Brussee H, et al. Anticardiolipin antibodies are no marker for survived myocardial infarction. Klin Wochenschr. 1990;68:594-596.
18. 18. Cortellaro M, Boschetti C, Cardilo M, Barbui T. Antiphospholipid antibodies in patients with previous myocardial infarction. Lancet. 1992;339:929-930. Letter.
19. 19. Phadke KV, Phillips RA, Clarke DTR, et al. Anticardiolipin antibodies in ischemic heart disease: marker or myth? Br Heart J. 1993;69:391-394.
20. 20. Yilmaz E, Adalet K, Yilmaz G, et al. Importance of serum anticardiolipin antibody levels in coronary heart disease. Clin Cardiol. 1994;17:117-121.
21. 21. Adler Y, Finkelstein Y, Zandeman-Goddard G, et al. The presence of antiphospholipid antibodies in acute myocardial infarction. Lupus. 1995;4:309-313.
22. 22. Klemp P, Cooper RC, Strauss FJ, et al. Anticardiolipin antibodies in ischemic heart disease. Clin Exp Immunol. 1988;74:254-257.
23. 23. Raghavan C, Ditchfield J, Taylor RJ, et al. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J Clin Pathol. 1993;46:1113-1115.
24. 24. Diaz MN, Becker RC. Anticardiolipin antibodies in patients with unstable angina. Cardiology. 1994;84:380-384.
25. 25. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation. 1979;59:607-609.
26. 26. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987;46:1-6.
27. 27. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;iii:1211-1214.
28. 28. Vermylen J, Blockmans D, Spitz B, Deckmyn H. Thrombosis and immune disorder. Clin Haematol. 1986; 15:393-412.
29. 29. Waddell CC, Brown JA. The lupus anticoagulant in 14 male patients. JAMA. 1982;248:2493-2495.
30. 30. Love PL, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Int Med. 1990; 112:682-698.
31. 31. Kalunian KC, Peter JB, Middlekauff HR, et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med. 1988;85:602-608.
32. 32. Manoussakis MN, Tzioufas AG, Silis MP, et al. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987;69:557-565.
33. 33. Morton KE, Krilis SA, Brown DW, et al. Coronary artery bypass graft failure-an autoimmune phenomenon? Lancet. 1986;ii:1953-1957.